| Detected | Trial | Change |
|---|---|---|
| 2026-07-21 | NCT05949580 Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care… |
Recruitment suspended |
| 2026-07-21 | NCT05949580 Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care… |
critical why stopped: null → "Transition of study Sponsor." |
| 2026-07-21 | NCT07282574 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of… |
Trial sites expanded: 91 -> 103 locations |
| 2026-07-21 | NCT07351058 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With… |
Trial sites expanded: 122 -> 163 locations |
| 2026-07-21 | NCT07351045 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With… |
Trial sites expanded: 128 -> 164 locations |
| 2026-07-21 | NCT05775289 A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus… |
Trial completed |
| 2026-07-21 | NCT05775289 A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus… |
date change Completion moved earlier: 2026-06-01 -> 2026-04-30 |
| 2026-07-21 | NCT07555938 Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in… |
Trial sites expanded: 7 -> 15 locations |
| 2026-07-21 | NCT07541079 A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant… |
Recruitment opened |
| 2026-07-19 | NCT07214766 A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery… |
Trial completed |
| 2026-07-19 | NCT06723106 Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) |
Trial sites expanded: 58 -> 62 locations |
| 2026-07-19 | NCT06723106 Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) |
date change Primary completion pushed: 2027-04-30 -> 2028-02-28 |
| 2026-07-19 | NCT06723106 Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) |
date change Completion pushed: 2027-04-30 -> 2028-02-28 |
| 2026-07-17 | NCT07158242 A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121)… |
Trial sites expanded: 12 -> 15 locations |
| 2026-07-17 | NCT05296798 A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo… |
Trial sites reduced: 206 -> 202 locations |
| 2026-07-17 | NCT07239336 Study of DONQ52 in Active Celiac Disease |
Trial sites expanded: 56 -> 62 locations |
| 2026-07-16 | NCT04158258 A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients… |
date change Primary completion pushed: 2026-06-30 -> 2026-07-31 |
| 2026-07-16 | NCT04158258 A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients… |
date change Completion pushed: 2026-06-30 -> 2026-07-31 |
| 2026-07-16 | NCT06780150 A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain… |
Primary endpoint(s) modified |
| 2026-07-16 | NCT05123703 A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in… |
Primary endpoint(s) modified |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-26 | NCT07670416 A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or… | Phase 3 | Recruiting |
| 2026-06-25 | NCT07667322 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and… | Phase 1 | Recruiting |
| 2026-06-24 | NCT07665723 An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05861986 | A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early… | Muscular Atrophy, Spinal | Recruiting |
| NCT06274515 | A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies | Breast Cancer | Recruiting |
| NCT05861999 | A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric… | Muscular Atrophy, Spinal | Recruiting |
| NCT04853251 | A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related… | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT05181618 | A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants… | Severe Hemophilia A | Active, Not Recruiting |
| NCT06795048 | A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants… | Neovascular Age-related Macular Degeneration (nAMD) | Active, Not Recruiting |
| NCT07025811 | A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants… | Dry Eye Disease | Active, Not Recruiting |
| NCT05224102 | A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented… | Diabetic Macular Edema | Active, Not Recruiting |
| NCT07483450 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of… | Relapsing Multiple Sclerosis | Active, Not Recruiting |
| NCT07609719 | A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple… | Multiple Sclerosis | Not Yet Recruiting |
| NCT05232929 | Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) | Spinal Muscular Atrophy | Active, Not Recruiting |
| Phase 3 | |||
| NCT06675955 | An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and… | Multiple Sclerosis | Recruiting |
| NCT06094010 | A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants… | Influenza | Recruiting |
| NCT05797610 | A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants… | Primary IgA Nephropathy | Recruiting |
| NCT06847542 | A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT05894239 | A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo… | Metastatic Breast Cancer | Recruiting |
| NCT05878769 | A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT06084936 | A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in… | Lymphoma | Recruiting |
| NCT06588855 | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also… | Moderately to Severely Active Ulcerative Colitis | Recruiting |
| NCT06790693 | A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… | Breast Cancer | Recruiting |
| NCT06819878 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With… | Moderately to Severely Active Crohns Disease | Recruiting |
| NCT07169578 | A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Alzheimers Disease | Recruiting |
| NCT03683251 | Extension Study for the Port Delivery System With Ranibizumab (Portal) | Neovascular Age-Related Macular Degeneration | Recruiting |
| NCT06065748 | A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a… | Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | Recruiting |
| NCT06819891 | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart… | Moderately to Severely Active Crohns Disease | Recruiting |